Email
Mot de passe
Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

They are looking to invest

medal 1
Ce profil est validé par 1 label.

Company

ERC

ERC_logo
11
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

NAMUR, Région wallonne, Belgium

Send a message

  • 4

    employees

Anglais

ERC

Anglais

ERC has developed a unique advanced cancer cell based immunotherapy invented by Pr. Apostolos Stathopoulos for the treatment of patients suffering from brain cancers. This therapeutic vaccine known as ERC1671 (Gliovac™) particularly targets high grade gliomas.

 

ERC seeks to eliminate cancer cells completely, leading to a cure through its unique cell-based immunotherapy approach that treats patients suffering from glioma or glioblastoma by directly...

See more

ERC has developed a unique advanced cancer cell based immunotherapy invented by Pr. Apostolos Stathopoulos for the treatment of patients suffering from brain cancers. This therapeutic vaccine known as ERC1671 (Gliovac™) particularly targets high grade gliomas.

 

ERC seeks to eliminate cancer cells completely, leading to a cure through its unique cell-based immunotherapy approach that treats patients suffering from glioma or glioblastoma by directly stimulating the patient’s immune system with whole cancer cells and cell extracts. ERC has developed a unique, patented process using whole cells and lysates of autologous (patient’s own tumour) and allogeneic tumour cells (from other individuals).

  • 2

    Followers

Our latest news

Team member(s)

Your request has been sent
Join this organization
Your request has been sent

Our network

Your request has been sent
Join this network
Your message has been sent

Certifications

ePitches EuroQuity
142 Entities

Communities

EUROQUITY BELGIQUE
SOWALFIN AU SERVICE DE LA CROISSANCE DES ENTREPRISES La communauté est réservée aux entreprises soutenues par le Groupe Sowalfin et à ses partenaires
74 Members

Our history

Start in 02/2008

  • 02/2008

    Creation of ERC

  • 10/2009

    The company obtained Advanced Medical Therapy Product status for Gliovac/ERC1671 from the EMA.

  • 01/2011

    The company obtained Orphan Drug status for Gliovac/ERC1671 from the US FDA and the status SME (EMA)

  • 09/2012

    First patient reaching total remission.

  • 01/2013

    Phase II FDA Approval in recurrent patients - recruiting. Orphan Drug Status granted by EMA.

to be continued ...